Standard
The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin. / Priemel, Petra A.; Grohganz, Holger; Gordon, Keith C. ; Rades, Thomas; Strachan, Clare.
In:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, No. 1, 2012, p. 187-193.
Research output: Contribution to journal › Journal article › peer-review
Harvard
Priemel, PA
, Grohganz, H, Gordon, KC
, Rades, T & Strachan, C 2012, '
The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin',
European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, no. 1, pp. 187-193.
https://doi.org/10.1016/j.ejpb.2012.05.012APA
Priemel, P. A.
, Grohganz, H., Gordon, K. C.
, Rades, T., & Strachan, C. (2012).
The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin.
European Journal of Pharmaceutics and Biopharmaceutics,
82(1), 187-193.
https://doi.org/10.1016/j.ejpb.2012.05.012Vancouver
Priemel PA
, Grohganz H, Gordon KC
, Rades T, Strachan C.
The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin.
European Journal of Pharmaceutics and Biopharmaceutics. 2012;82(1):187-193.
https://doi.org/10.1016/j.ejpb.2012.05.012Author
Priemel, Petra A. ; Grohganz, Holger ; Gordon, Keith C. ; Rades, Thomas ; Strachan, Clare. / The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin. In: European Journal of Pharmaceutics and Biopharmaceutics. 2012 ; Vol. 82, No. 1. pp. 187-193.
Bibtex
@article{1c2226514c46405f862473d81f4b50d9,
title = "The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin",
author = "Priemel, {Petra A.} and Holger Grohganz and Gordon, {Keith C.} and Thomas Rades and Clare Strachan",
year = "2012",
doi = "10.1016/j.ejpb.2012.05.012",
language = "English",
volume = "82",
pages = "187--193",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin
AU - Priemel, Petra A.
AU - Grohganz, Holger
AU - Gordon, Keith C.
AU - Rades, Thomas
AU - Strachan, Clare
PY - 2012
Y1 - 2012
U2 - 10.1016/j.ejpb.2012.05.012
DO - 10.1016/j.ejpb.2012.05.012
M3 - Journal article
C2 - 22683936
VL - 82
SP - 187
EP - 193
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
SN - 0939-6411
IS - 1
ER -
